Diabetes Archive

Baseline HbA1c, BMI Do Not Affect Clinical Outcomes of Fast-Acting Insulin Aspart

Baseline HbA1c, BMI Do Not Affect Clinical Outcomes of Fast-Acting Insulin Aspart

Baseline HbA1c and BMI do not significantly influence treatment differences between mealtime fast-acting insulin aspart and other basal insulin therapies.

Risk Factors Associated With Cataract Surgery in Patients With T2D

Risk Factors Associated With Cataract Surgery in Patients With T2D

People with type 2 diabetes are at significantly higher risk for cataract surgery, especially people in younger age groups, and factors including serum lipid levels, hypoglycemia, and ethnicity are able to predict likelihood of undergoing surgery.

Reducing Systolic Blood Pressure With Liraglutide: Predictors and Correlates

Reducing Systolic Blood Pressure With Liraglutide: Predictors and Correlates

Patients with type 2 diabetes treated with liraglutide experience a greater reduction in systolic BP if they have lower baseline continuous glucose monitoring values and higher diastolic BP.

GLP-1 Receptor Agonists Not Associated With Increased Diabetic Retinopathy Risk

GLP-1 Receptor Agonists Not Associated With Increased Diabetic Retinopathy Risk

Using data from the FDA Adverse Event Reporting System, researchers found no association between the use of GLP-1 receptor agonists and risk for diabetic retinopathy.

Should Massively Parallel Sequencing Be Used to Screen for Maturity-Onset Diabetes of the Young?

Should Massively Parallel Sequencing Be Used to Screen for Maturity-Onset Diabetes of the Young?

The use of targeted massively parallel sequencing to screen children with diabetes for maturity-onset diabetes of the young is more effective and less costly than the current standard care and may improve patient quality of life.

Sustained Improvements in CVD Risk With Intensive T2D Intervention

Sustained Improvements in CVD Risk With Intensive T2D Intervention

Intensive multifactorial interventions that are implemented in a multi-ethnic population with type 2 diabetes led to sustained improvements in a model of cardiovascular disease outcomes.

Interpregnancy Period Should Maximize Women's Health

Interpregnancy Period Should Maximize Women's Health

Providers should maximize women's health during the interpregnancy period, continuing care beyond the immediate postpartum period.

Worse Outcomes for Patients With Diabetes Undergoing PCI Despite Therapeutic Advances

Worse Outcomes for Patients With Diabetes Undergoing PCI Despite Therapeutic Advances

Patients with diabetes have worse angiographic and clinical outcomes after percutaneous coronary intervention compared with patients without diabetes, even with the use of contemporary stents.

Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D

Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D

Professional and personal continuous glucose monitoring systems exhibit similar accuracy in both inpatient and home settings, with both having lower sensor performance during hypoglycemic episodes.

BMI Change During Male Puberty Associated With Risk for Type 2 Diabetes

BMI Change During Male Puberty Associated With Risk for Type 2 Diabetes

Increased BMI during puberty might worsen risk for adult type 2 diabetes in men.

Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes

Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes

Early triple combination therapy with metformin, dapagliflozin, and saxagliptin offers better improvements in glycemic control than a dual therapy strategy with metformin and sitagliptin in patients with uncontrolled type 2 diabetes.

Type 2 Diabetes Risk Lower in Women With Active Migraine

Type 2 Diabetes Risk Lower in Women With Active Migraine

Women with active migraine have a lower risk for type 2 diabetes.

ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care

ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care

The ADA published its 2019 Standards of Medical Care in Diabetes, an evidence-based document intended to provide clinicians, patients, and other stakeholders in the diabetes treatment landscape with up-to-date recommendations.

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

For this study, the authors identified randomized controlled trials (RCTs) that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.

Metabolic Syndrome Highly Prevalent in Patients With Plaque Psoriasis

Metabolic Syndrome Highly Prevalent in Patients With Plaque Psoriasis

Metabolic syndrome and psoriatic arthritis were highly prevalent comorbidities in patients with plaque psoriasis.

T2D Linked to Decline in Verbal Memory, Fluency in Older Adults

T2D Linked to Decline in Verbal Memory, Fluency in Older Adults

Type 2 diabetes is associated with declines in verbal memory and fluency among older community-dwelling adults.

Nurse Practitioners and Physician Assistants can effectively manage chronic conditions, fill gaps in primary care

In this study, no significant differences were seen in the diabetes outcomes of patients managed by nurse practitioners or physician assistants compared to patients managed by physician primary care providers.

Diabetes patients with high-deductible health care plans may delay seeking crucial care

In this study, patients with high-deductible health care plans were more likely to delay seeking care for the treatment of macrovascular complications of diabetes.

Low-Risk Patients With T2D May Be Self-Testing Blood Glucose Too Often

Low-Risk Patients With T2D May Be Self-Testing Blood Glucose Too Often

Patients with stable type 2 diabetes may be unnecessarily self-monitoring blood glucose levels despite this practice being recognized as a low-value service.

Risk for Hospitalization for Heart Failure Greater With Diabetes

Risk for Hospitalization for Heart Failure Greater With Diabetes

Despite declining incidence, heart failure hospitalization is increased among individuals with diabetes.

Liraglutide significantly reduces risk for major cardiac events in elderly patients with diabetes

A significant reduction in major cardiac events among elderly patients was seen in the liraglutide treatment group.

SYNTAX Score: A Predictive Scale for Adverse CV Events in Patients With Diabetes, CAD Undergoing PCI

SYNTAX Score: A Predictive Scale for Adverse CV Events in Patients With Diabetes, CAD Undergoing PCI

SYNTAX score, a validated prediction score used to estimate risk with PCI, is modestly correlated with hard cardiovascular events and is significantly correlated with major adverse cardiac and cerebrovascular events

Clinical Indicators of Risk for Addison Disease in Patients With T1D

Clinical Indicators of Risk for Addison Disease in Patients With T1D

Treatment of thyroid disease, severe infections, glucagon prescriptions, and diabetic retinopathy occur more frequently in individuals with type 1 diabetes who are subsequently diagnosed with Addison disease.

High Prevalence of Fasting-Evoked Hypoglycemia in Diabetes

High Prevalence of Fasting-Evoked Hypoglycemia in Diabetes

About 17 percent of patients with diabetes report experiencing hypoglycemia when fasting for lab tests.

A Risk Prediction Tool for Hip Fracture in Type 2 Diabetes

A Risk Prediction Tool for Hip Fracture in Type 2 Diabetes

A hip fracture risk tool for patients with type 2 diabetes performed well in predicting incident hip fractures using readily available variables.

Hypertensive Disorders in Pregnancy, Postpartum BMI Linked to T2D Risk

Hypertensive Disorders in Pregnancy, Postpartum BMI Linked to T2D Risk

Postpartum women with an elevated BMI score and a history of hypertensive disorders during pregnancy have an increased risk of developing type 2 diabetes.

Radiographic Knee OA Not Correlated With Diabetes, Altered Glucose Metabolism

Radiographic Knee OA Not Correlated With Diabetes, Altered Glucose Metabolism

Investigators examined whether there is a connection between diabetes and increased risk for knee osteoarthritis.

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men

Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only.

Chronic Disease Education Can Improve Patient Self-Management

Chronic Disease Education Can Improve Patient Self-Management

An educational intervention can improve patients' ability to self-manage their chronic diseases.

Normalized HbA1c Levels Facilitate Improved Neuropathy Outcomes in T2D

Normalized HbA1c Levels Facilitate Improved Neuropathy Outcomes in T2D

Normalized HbA1c levels facilitated improvement in neuropathy and nephropathy in type 2 diabetes of a short duration.

Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain

Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain

The majority of patients being considered for corticosteroid injections to treat chronic pain may be at high risk for untreated diabetes.

Fear Impacts Quality of Life for Young Adults With Type 1 Diabetes

Fear Impacts Quality of Life for Young Adults With Type 1 Diabetes

Fear of complications and frustration at the amount of time required to manage type 1 diabetes impact the quality of life of young adults with the disease.

Serious Adverse Events Linked to SGLT2 Inhibitors

Serious Adverse Events Linked to SGLT2 Inhibitors

Compared with GLP-1 receptor agonists, the use of SGLT2 inhibitors is associated with an increased risk for diabetic ketoacidosis and lower limb amputation.

Skin Autofluorescence Predicts T2D, Heart Disease, Mortality

Skin Autofluorescence Predicts T2D, Heart Disease, Mortality

Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease (CVD), and mortality in the general population.

Impaired Glucose Metabolism May Affect Mood Stabilizer Response in Bipolar Disorder

Impaired Glucose Metabolism May Affect Mood Stabilizer Response in Bipolar Disorder

High blood sugar levels may put patients with bipolar disorder at risk of not responding to lithium and other mood stabilizer treatments.

Nutrition Assistance Program Lowers Cost-Related Medication Nonadherence in Diabetes

Nutrition Assistance Program Lowers Cost-Related Medication Nonadherence in Diabetes

Older adults with diabetes who participate in the Supplemental Nutrition Assistance Program are significantly less likely to report cost-related medication nonadherence compared with nonparticipants.

Mediterranean Diet, Physical Activity Effective for Weight Loss, Decreased Cardiovascular Events

Mediterranean Diet, Physical Activity Effective for Weight Loss, Decreased Cardiovascular Events

A 12-month intensive lifestyle intervention including an energy-restricted Mediterranean diet, increased physical activity, and behavioral support for overweight/obese patients was found to be beneficial in decreasing adiposity and cardiovascular events.

Unhealthy Lifestyle and Rotating Night Shifts Put Nurses at Higher Risk for T2D

Unhealthy Lifestyle and Rotating Night Shifts Put Nurses at Higher Risk for T2D

Female nurses who frequently work rotating night shifts and adhere to an unhealthy lifestyle are at significantly greater risk of developing type 2 diabetes.

Cost-Related Insulin Underuse in Patients With Diabetes

Cost-Related Insulin Underuse in Patients With Diabetes

About one in four patients report cost-related insulin underuse, which is associated with poor glycemic control.

Comparative Assessment of Diabetes Outcomes With Physician, NP, PA Providers

Comparative Assessment of Diabetes Outcomes With Physician, NP, PA Providers

Could type of clinician rendering care influence outcomes for patients with diabetes?

Diet Quality and Glycemic Control in Women With Gestational Diabetes

Diet Quality and Glycemic Control in Women With Gestational Diabetes

Women with gestational diabetes can improve glycemic control by improving their diet.

Most Foods Containing Fructose Do Not Have Harmful Effect on Glycemic Control

Most Foods Containing Fructose Do Not Have Harmful Effect on Glycemic Control

Several foods with fructose-containing sugars have harmful effects on glycemic control and add unneeded energy to the diet, but these effects may be mediated by energy and food source.

High-Deductible Insurance Linked to Delayed Care for Diabetes Complications

High-Deductible Insurance Linked to Delayed Care for Diabetes Complications

Mandated enrollment in a high-deductible insurance plan among persons with diabetes was associated with delays in seeking care for diabetes complications.

Endocrine Society: Policy and Practice Changes Necessary to Improve Access to Insulin

Endocrine Society: Policy and Practice Changes Necessary to Improve Access to Insulin

The rising cost of insulin has made it increasingly difficult for patients with diabetes to receive affordable, life-saving medication, especially patients from low-income backgrounds, patients with high deductibles, and uninsured patients.

Plasma Acylcarnitines May Indicate Risk for Type 2 Diabetes

Plasma Acylcarnitines May Indicate Risk for Type 2 Diabetes

Among individuals at a high risk for cardiovascular disease, a panel of short- and long-chain acylcarnitines was significantly associated with the incidence of type 2 diabetes.

Elevated Triglyceride Levels Affect Glycemic Control in Type 2 Diabetes

Elevated Triglyceride Levels Affect Glycemic Control in Type 2 Diabetes

Reducing triglyceride levels in patients with type 2 diabetes may help them attain more optimal glycemic control.

Large For Gestational Age a Strong Predictor of Overweight, Obesity in Childhood

Large For Gestational Age a Strong Predictor of Overweight, Obesity in Childhood

Large for gestational age (LGA) is a stronger marker than maternal diabetes for subsequently being overweight or obese in early childhood.

Sharp Increase in Projected Global Insulin Use From 2018 to 2030

Sharp Increase in Projected Global Insulin Use From 2018 to 2030

From 2018 to 2030, the insulin required to treat type 2 diabetes is expected to increase more than 20 percent.

Ezetimibe Plus Statin Therapy Reduces Ischemic Risk in Polyvascular Disease, T2D

Ezetimibe Plus Statin Therapy Reduces Ischemic Risk in Polyvascular Disease, T2D

The addition of ezetimibe to simvastatin reduced ischemic risk compared with placebo, with consistent relative risk reductions in patients with and without polyvascular disease.

Digital Obesity Treatment in Primary Care May Help Disadvantaged Patients

Digital Obesity Treatment in Primary Care May Help Disadvantaged Patients

Socioeconomically challenged patients with obesity and elevated cardiovascular risk may benefit from digital obesity treatment combined with health system resources.

Ultrasound of Deltoid Muscle May Predict Diabetes

Ultrasound of Deltoid Muscle May Predict Diabetes

The ultrasound appearance of an echogenic deltoid muscle may predict diabetes and prediabetes.

ACC Releases Recommendations for Treatment of Patients With T2D and ASCVD

ACC Releases Recommendations for Treatment of Patients With T2D and ASCVD

The American College of Cardiology published an expert consensus statement regarding decision considerations for novel cardiovascular risk reduction therapies in patients with type 2 diabetes and atherosclerotic cardiovascular disease.

Type 1 Diabetes Confers Extra Risk for Autoimmune Diseases

Type 1 Diabetes Confers Extra Risk for Autoimmune Diseases

Type 1 diabetes predisposes children and adults to autoimmune diseases, which can impair glucose metabolism and interfere with insulin therapy.

Coronary Bypass Grafting Superior to Percutaneous Coronary Intervention With Drug-Eluting Stents for Reducing Mortality in Diabetes

Coronary Bypass Grafting Superior to Percutaneous Coronary Intervention With Drug-Eluting Stents for Reducing Mortality in Diabetes

Coronary artery bypass grafting may be a superior revascularization strategy in patients with diabetes and multivessel disease.

Lifestyle Intervention Program Reduces Diabetes, Metabolic Syndrome Risk

Lifestyle Intervention Program Reduces Diabetes, Metabolic Syndrome Risk

A 12-month interdisciplinary lifestyle intervention program for prediabetic and obese patients was found to significantly reduce the risk for development of diabetes and metabolic syndrome.

Lixisenatide Associated With Beneficial Renal Outcomes in Patients With T2D

Lixisenatide Associated With Beneficial Renal Outcomes in Patients With T2D

In patients with T2D and acute coronary syndrome, treatment with the short-acting glucagon-like peptide-1 (GLP-1) receptor agonist lixisenatide reduced urinary albumin-to-creatinine ratio.

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization

Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.

Ketogenic Diet for the Management of T2D and Associated Long-Term Complications

Ketogenic Diet for the Management of T2D and Associated Long-Term Complications

With obesity reaching epidemic proportions, and its known association with many metabolic disorders such as type 2 diabetes, dyslipidemia, hypertension, and atherosclerosis, it is worthwhile to look at nutritional approaches to managing these chronic conditions.

Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk

Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk

Linagliptin added to usual care compared with placebo added to usual care resulted in a noninferior risk for a composite cardiovascular or renal outcome over a median 2.2 years.

AMA, CDC Launch Campaign to Raise Awareness About Prediabetes

AMA, CDC Launch Campaign to Raise Awareness About Prediabetes

More than one-third of Americans have prediabetes, but 90 percent of them do not know they have it.

Exposure to Maternal Diabetes Increases Risk for ADHD in Offspring

Exposure to Maternal Diabetes Increases Risk for ADHD in Offspring

The 3 main types of diabetes during pregnancy were associated with offspring ADHD risk in a hierarchical order.

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

High circulating total prolactin concentrations may be linked with a lower risk for type 2 diabetes in women.

Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes

Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes

Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease.

Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection

Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection

The study compared US administrative claims data of HCV patients with ≥12 weeks of dispensed DAA therapy (N = 17,848) to untreated HCV patients with follow-up data (N = 108,350).

ADA Issues Position Statement on Comprehensive Care for Pediatric T2D

ADA Issues Position Statement on Comprehensive Care for Pediatric T2D

The American Diabetes Association issued a position statement outlining the recognition, management, and prevention of T2D in the pediatric population.

Peer Support Reduces Hospitalizations in People With Diabetes and Depression

Peer Support Reduces Hospitalizations in People With Diabetes and Depression

Patients with diabetes and depressive symptoms who received community-based peer support for diabetes management reported less frequent acute care visits and hospitalizations than patients with diabetes without depressive symptoms.

HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality

HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality

People who do not have diabetes or cardiovascular disease but have high hemoglobin A1c variability tend to be at greater risk for major adverse cardiovascular events and all-cause mortality.

Multiple Daily Injections vs Insulin Pump Therapy in Pregnant Women With T1D

Multiple Daily Injections vs Insulin Pump Therapy in Pregnant Women With T1D

Pregnant women with T1D who received MDI therapy had a larger decrease in HbA1c levels and were less likely to report gestational hypertension, neonatal hypoglycemia, and NICU admissions than women who used insulin pump therapy during pregnancy.

Pathogenesis of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass in T2D

Pathogenesis of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass in T2D

Postprandial hypoglycemia may occur after Roux-en-Y gastric bypass in patients with type 2 diabetes, independent from diabetes remission.

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization in T2D

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization in T2D

Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.

Measuring Time in Range During CGM May Be Useful Outcome Metric for Clinical Trials

Measuring Time in Range During CGM May Be Useful Outcome Metric for Clinical Trials

TIR is strongly associated with the risk of microvascular complications and should be an acceptable end point for clinical trials.

Prevalence of Arthritis in Adults With Prediabetes

Prevalence of Arthritis in Adults With Prediabetes

About 1 in 3 adults with prediabetes has arthritis, and half of those with both conditions are physically inactive and/or obese.

Acute and Persistent Prothrombic Effects Observed With Antecedent Hypoglycemia in T2D

Acute and Persistent Prothrombic Effects Observed With Antecedent Hypoglycemia in T2D

Hypoglycemia was associated with early and late prothrombotic changes in the fibrin network in individuals with type 2 diabetes.

Insulins

Insulin products chart with pharmacokinetic properties.

Insulin Administration

Insulin preparations categorized by rapid-, short-, intermediate- and long-acting. Information such as the route, administration as well as the mixing of insulins is provided.

Patients With T2D and Sickle-Cell Trait at Higher Risk for Complications

Patients With T2D and Sickle-Cell Trait at Higher Risk for Complications

Diabetic complications were more prevalent in patients with both sickle-cell trait and T2D than in patients with T2D alone.

AHA, ADA Announce Joint Education Initiative to Reduce CVD Deaths in T2D

AHA, ADA Announce Joint Education Initiative to Reduce CVD Deaths in T2D

The ADA and the AHA launch a long-term awareness and education initiative for the prevention of deaths due to cardiovascular complications in patients with T2D.

Long-Term Efficacy and Safety of Dapagliflozin for Type 1 Diabetes

Long-Term Efficacy and Safety of Dapagliflozin for Type 1 Diabetes

After 52 weeks, dapagliflozin was well tolerated and led to a clinically relevant improvement in glycemic control and weight loss without additional risk for hypoglycemia.

Type 2 Diabetes May Have Adverse Effect on Parkinson Disease Symptoms, Outcomes

Type 2 Diabetes May Have Adverse Effect on Parkinson Disease Symptoms, Outcomes

Patients with both Parkinson disease and type 2 diabetes were more likely to have cardiovascular comorbidities than those with only Parkinson disease.

Hypoglycemia Following Antifungal Treatment in Patient With Type 1 Diabetes

Hypoglycemia Following Antifungal Treatment in Patient With Type 1 Diabetes

"This is the first report of decreased insulin requirements in a patient with [T1D] correlating with micafungin administration," noted the authors.

Risk for T2D Increases Following Total or Partial Colectomy

Risk for T2D Increases Following Total or Partial Colectomy

Patients who have the entire or left side of the colon removed show increased risk for developing type 2 diabetes in the 18 years following surgery.

Undiagnosed Prediabetes Prevalent in Men With Primary Infertility

Undiagnosed Prediabetes Prevalent in Men With Primary Infertility

Approximately 15% of men experiencing infertility may have undiagnosed prediabetes.

Plant-Based Diets Beneficial for Adults With Type 2 Diabetes

Plant-Based Diets Beneficial for Adults With Type 2 Diabetes

For adults with type 2 diabetes, plant-based diets can improve psychological health, quality of life, hemoglobin A1c levels, and weight.

Lipidome Profiles Stratify Risk for Type 2 Diabetes

Lipidome Profiles Stratify Risk for Type 2 Diabetes

Early detection of lipidome characteristics could help identify the early onset of type 2 diabetes.

Diabetes Education Week 2018: Patient Resources for Your Practice

Diabetes Education Week 2018: Patient Resources for Your Practice

In recognition of National Diabetes Education Week, Endocrinology Advisor compiled a list of resources to assist clinicians when educating patients with diabetes about their condition.

Prevalence of Gestational Diabetes Increased From 2012 to 2016

Prevalence of Gestational Diabetes Increased From 2012 to 2016

The prevalence of gestational diabetes was 6.0 percent in 2016, with a slight increase seen from 2012 to 2016.

Intensive BP, Lipid Control in T2D May Increase Risk for Adverse Kidney Events

Intensive BP, Lipid Control in T2D May Increase Risk for Adverse Kidney Events

Intensive BP control and fenofibrate use in patients with T2D who are at high risk for CVD may increase the risk for adverse kidney events.

Increasing Incidence of Diabetes After Immune Checkpoint Inhibitor Therapy

Increasing Incidence of Diabetes After Immune Checkpoint Inhibitor Therapy

There is increased reporting of rapidly progressive diabetes associated with immune checkpoint inhibitor therapy.

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

The impurity was identified following laboratory testing conducted by the Food and Drug Administration (FDA); this is the first non-valsartan product that the Agency has found to contain NDEA.

Exposure to Ready-to-Eat Food Outlets Associated With Risk for Type 2 Diabetes

Exposure to Ready-to-Eat Food Outlets Associated With Risk for Type 2 Diabetes

Access to ready-to-eat outlets that sell food for instant consumption is associated with greater risk for type 2 diabetes.

Triponderal Mass Index Not Superior to BMI in Estimating Obesity Outcomes

Triponderal Mass Index Not Superior to BMI in Estimating Obesity Outcomes

Triponderal mass index alone and in combination with body mass index (BMI) or subscapular skinfold thickness was not superior to BMI alone for estimating obesity-related outcomes in adulthood.

Bardoxolone Methyl Leads to Weight Loss in T2D with Concurrent Chronic Kidney Disease

Bardoxolone Methyl Leads to Weight Loss in T2D with Concurrent Chronic Kidney Disease

Treatment with bardoxolone methyl resulted in significant weight loss and showed no evidence of muscle wasting in patients with type 2 diabetes and stage IV chronic kidney disease.

Canagliflozin Approved to Reduce Risk for Cardiovascular Events in T2D

Canagliflozin Approved to Reduce Risk for Cardiovascular Events in T2D

The effect of Invokana on CV risk was evaluated in the CANVAS (CANagliflozin cardioVascular Assessment Study) Program in >10,000 adults with T2D who had established CV disease or were at risk for CV disease with ≥2 risk factors.

Hyperglycemia, Obesity, Hypertriglyceridemia Negatively Related to CAN in T2D

Hyperglycemia, Obesity, Hypertriglyceridemia Negatively Related to CAN in T2D

Hyperglycemia, obesity, and hypertriglyceridemia in type 2 diabetes are negatively related to indices of cardiovascular autonomic neuropathy.

Weight Regain After Bariatric Surgery to Predict Clinical Outcomes

Weight Regain After Bariatric Surgery to Predict Clinical Outcomes

Measures that quantified weight regain as a percentage of maximum weight lost had the strongest association and best fit with clinical outcomes.

Early Natural Menopause Linked to Life Expectancy, Years With T2D

Early Natural Menopause Linked to Life Expectancy, Years With T2D

Compared with women who experience normal or late menopause, women who experience early natural menopause have a shorter life expectancy and spend fewer years without type 2 diabetes.

Dual GIP, GLP-1 Receptor Agonist Effective for Weight Loss, Glucose Control in T2D

Dual GIP, GLP-1 Receptor Agonist Effective for Weight Loss, Glucose Control in T2D

LY3298176, a dual GIP and GLP-1 receptor agonist, showed significantly better efficacy than dulaglutide with regard to glucose control and weight loss in type 2 diabetes.

Type 2 Diabetes an Independent Risk Factor for Coronary Artery Disease

Type 2 Diabetes an Independent Risk Factor for Coronary Artery Disease

Type 2 diabetes is an independent risk factor for sudden cardiac arrest and death in patients with coronary artery disease with preserved ejection fraction.

Biomarkers of Dairy Fat Consumption Inversely Associated With Type 2 Diabetes Risk

Biomarkers of Dairy Fat Consumption Inversely Associated With Type 2 Diabetes Risk

Researchers found that higher levels of fatty acid biomarkers 15:0, 17:0, and trans-16:1n7 were inversely associated with risk for T2D.

Sign Up for Free e-Newsletters



CME Focus